TrialThe Lancet. Oncology2021

Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.

Nancy Y Lee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.